Reaction Details |
| Report a problem with these data |
Target | Gastrin/cholecystokinin type B receptor |
---|
Ligand | BDBM50196149 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_418719 (CHEMBL912951) |
---|
Ki | >10000±n/a nM |
---|
Citation | Allison, BD; Phuong, VK; McAtee, LC; Rosen, M; Morton, M; Prendergast, C; Barrett, T; Lagaud, G; Freedman, J; Li, L; Wu, X; Venkatesan, H; Pippel, M; Woods, C; Rizzolio, MC; Hack, M; Hoey, K; Deng, X; King, C; Shankley, NP; Rabinowitz, MH Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists. J Med Chem49:6371-90 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Gastrin/cholecystokinin type B receptor |
---|
Name: | Gastrin/cholecystokinin type B receptor |
Synonyms: | CCK-2 receptor | CCK-B receptor | CCK-BR | CCKBR | CCKRB | Cholecystokinin A | Cholecystokinin receptor | Cholecystokinin-2 Receptor | GASR_HUMAN | Gastrin/cholecystokinin type B receptor |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 48445.79 |
Organism: | Homo sapiens (Human) |
Description: | Stable expression of human CCK-2 receptors in HEK 293 cells. |
Residue: | 447 |
Sequence: | MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITL
YAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF
IFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWL
LSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGL
ISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRS
RPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDG
PGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRAL
PDEDPPTPSIASLSRLSYTTISTLGPG
|
|
|
BDBM50196149 |
---|
n/a |
---|
Name | BDBM50196149 |
Synonyms: | 4-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]benzoyl]-morpholine | CHEMBL217276 |
Type | Small organic molecule |
Emp. Form. | C17H16N4O4S2 |
Mol. Mass. | 404.463 |
SMILES | O=C(N1CCOCC1)c1ccccc1NS(=O)(=O)c1cccc2nsnc12 |
Structure |
|